-
公开(公告)号:US09044480B1
公开(公告)日:2015-06-02
申请号:US13412167
申请日:2012-03-05
申请人: Tami Pilot-Matias , Isabelle A. Gaultier , Rakesh L. Tripathi , Christine A. Collins , Daniel E. Cohen , Barry M. Bernstein
发明人: Tami Pilot-Matias , Isabelle A. Gaultier , Rakesh L. Tripathi , Christine A. Collins , Daniel E. Cohen , Barry M. Bernstein
IPC分类号: A61K38/00 , A61K31/33 , A61K31/44 , A61K31/497
CPC分类号: A61K31/497 , A61K31/427 , A61K2300/00
摘要: The present invention features methods of using Compound I to suppress HCV mutants, treat treatment-experienced HCV patients, and treat HCV patients having non-CC IL28B rs12979860 genotype.
摘要翻译: 本发明的特征在于使用化合物I抑制HCV突变体,治疗经历的HCV患者以及治疗具有非CC IL28B rs12979860基因型的HCV患者的方法。